Fig. 1
From: Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Study characteristics and microbiota composition difference in different irAEs status. A Study characteristics and demographic proportion of irAEs. B Microbiota composition (Phylum level) in the different studies of individuals. C Microbiota composition (Phylum level) in the different irAEs status analyzed with all cohorts demonstrated in 1A. D Visualization of differential microbiota in anti-CTLA-4 cohorts (Dubin and Chaput) by volcano plot. E Visualization of differential microbiota in anti-PD-1/PD-L1 cohorts (Zhang, Hakozaki, Chau, and McCulloch) by volcano plot